Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

Simple item page
dc.contributor.authorAbou Ali, Bilal
dc.contributor.authorNader, Ralph
dc.contributor.authorTamim, Hani Mohammed
dc.contributor.authorEid, Toufic A.
dc.contributor.authorBoulos, Fouad I.
dc.contributor.authorKhoury, Nabil El
dc.contributor.authorAkel, Samir R.
dc.contributor.authorHaidar, Rachid K.
dc.contributor.authorSaghieh, Saïd S.
dc.contributor.authorAbboud, Miguel Raul
dc.contributor.authorMuwakkit, Samar A.
dc.contributor.authorEl-Solh, Hassan
dc.contributor.authorSaab, Raya H.
dc.contributor.departmentPediatrics and Adolescent Medicine
dc.contributor.departmentInternal Medicine
dc.contributor.departmentRadiation Oncology
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.departmentDiagnostic Radiology
dc.contributor.departmentSurgery
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:10:31Z
dc.date.available2025-01-24T12:10:31Z
dc.date.issued2014
dc.description.abstractTreatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries. © 2014 Wiley Periodicals, Inc.
dc.identifier.doihttps://doi.org/10.1002/pbc.24926
dc.identifier.eid2-s2.0-84901989831
dc.identifier.pmid24395458
dc.identifier.urihttp://hdl.handle.net/10938/32317
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofPediatric Blood and Cancer
dc.sourceScopus
dc.subjectEwing sarcoma
dc.subjectPediatric
dc.subjectPrognostic factors
dc.subjectAdolescent
dc.subjectChild
dc.subjectChild, preschool
dc.subjectDisease-free survival
dc.subjectFemale
dc.subjectFollow-up studies
dc.subjectHumans
dc.subjectLebanon
dc.subjectMale
dc.subjectRetrospective studies
dc.subjectSarcoma, ewing
dc.subjectSurvival rate
dc.subjectArticle
dc.subjectCancer chemotherapy
dc.subjectCancer patient
dc.subjectClinical article
dc.subjectDeveloping country
dc.subjectEvent free survival
dc.subjectFebrile neutropenia
dc.subjectFollow up
dc.subjectHuman
dc.subjectHuman tissue
dc.subjectMucosa inflammation
dc.subjectOutcome assessment
dc.subjectOverall survival
dc.subjectPostoperative hemorrhage
dc.subjectPriority journal
dc.subjectRetrospective study
dc.subjectSeptic shock
dc.subjectTertiary health care
dc.titleOutcome of Ewing sarcoma in a multidisciplinary setting in Lebanon
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2014-5267.pdf
Size:
469.15 KB
Format:
Adobe Portable Document Format
Download

Collections

Pediatrics and Adolescent Medicine
Diagnostic Radiology
Internal Medicine
Pathology and Laboratory Medicine
Radiation Oncology
Surgery